Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-04-21
1994-11-29
Chan, Nicky
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549445, 549446, 549447, 549362, A61K 3136, C07D31754
Patent
active
053691270
ABSTRACT:
Compounds of the formula ##STR1## where W is (CH.sub.2).sub.n where n is 1 or 2, or n is O and W represents lower alkyl groups attached to each oxygen;
REFERENCES:
patent: 5066644 (1991-11-01), Poli et al.
patent: 5091528 (1992-02-01), Gluchowski
patent: 5151440 (1992-09-01), Gluchowski
Barreiro et al., J. Chem. Res. Symop., 7, 220-1 (1985) (C.A. 104: 19430c, 1986).
Bito, L. Z., Applied Pharmacology in the Medical Treatment of Glaucomas, Drance, S. M. and Neufeld, A. H. eds., New York, Grune & Stratton, 1984 pp. 477-505.
Journal of Medicinal Chemistry 1975, vol. 18, pp. 1094-1098 by Bender et al.
Bito, L. Z., Biological Protection with Prostaglandins, Cohen, M. M., ed., Boca Raton Fla. CRC Press Inc., 1985, pp. 231-252.
M. S. Starr, Exp. Eye Res. 11, 170-177 (1971).
Burk Robert M.
Woodward David F.
Allergan Inc.
Baran Robert J.
Chan Nicky
Szekeres Gabor L.
Voet Martin A.
LandOfFree
1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular h does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular h, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular h will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-74488